The host proteins SERINC 3 and 5 (SERINC3/5) are inhibitors of HIV-1 infectivity that are counteracted by Nef. Introduction of mutations to the highly conserved FPD121-123 motif in Nef resulted in disruption of Nef’s ability to counteract SERINC5 and enhance infectivity. Because this region encompasses HLA-restricted CTL epitopes, we hypothesized certain naturally arising HLA-driven mutations may impair Nef’s ability to SERINC5 and affect patients’ disease progression.
Nef genes were PCR-amplified from plasma viral RNA of treatment-naïve, chronically HIV-1-infected subjects (N=375) recruited in Japan. The amplified fragments were directly sequenced and cloned in to a plasmid for functional assays of their gene products. Nef’s ability to counteract SERINC3/5 was assessed by infectivity of viral particles that were produced by co-transfection of NL43 and the patient-derived nef genes to Jurkat cells expressing SV40 Large T antigen (JTAg) and JTAg cells lacking expression of SERINC3/5.
The phylogenetically-informed statistical approach revealed that Y120F and Q125H mutations located close to the FPD 121-123 motif were significantly enriched in Nef sequences from subjects harboring HLA-B*51:01 that was known to present 120YFPDWQNYT128 as a CTL epitope. Interestingly, the number of the two mutations (120F/125H) was significantly inversely correlated with the plasm viral load; whereas no other HLA-associated polymorphisms showed similar trend. Infectivity assays revealed that the patient-derived Nef clones carrying the double 120F/125H mutations exhibited impaired ability to counteract SERINC3/5 and that the observed impairment was restored when reversion mutations (120Y/125Q) were introduced. Corroboratively, Western blot analysis of viral particles revealed that the Nef-mediated inhibition of SRINC5 incorporation to progeny viral particles was impaired in Nef clones harboring the double 120F/125H mutations, compared to those harboring the consensus 120Y/125Q. In contrast, Nef functions of CD4 and HLA class I downregulation remained unchanged regardless of the Nef genotype of 120Y/125Q or 120F/125H.
Taken together, these results suggested that the immune-driven Nef mutations 120F/125H located at the highly conserved FPD121-123 motif impose fitness cost to Nef-mediated counteraction of SERINC5 and thereby viral replication in infected hosts.